Jan. 16, 2012

Chinese Chemical Industry Trends: A Look at Market Drivers

Chinese Chemical Industry Trends, read an article by Dr. Bernhard Hartmann, Managing Director, A.T. Kearney China and Dr. Kai Pflug, CEO, Management Consulting - Chemicals, at the CHEManger Europe portal http://www.chemanager-online.com/   moreAug. 01, 2011

Top 10 Pharma Companys

Top 10 Pharma Companys: Total revenue (in blue -Umsatz (german)) and expenses for R&D (in grey (Ausgaben Forschung und Entwicklung (german)) worldwide in 2010 (*in US$ billions).
For example Pfizer had a total revenue of about US$ 58.6 billion, and invested about US$ 9.41 billion in R&D.
Source: Diverse Sources (Company Information), Pharmaceutical Executive © Statista 2011 moreMay. 09, 2011

Frost & Sullivan Study on "Western European High Content Screening Market"

Frost & Sullivan published a study on the Western European High Content Screening Market beginning of March 2011. The study gives an overview on the High Content Screening Market, especially in the markets of cell based assays, imaging and cell analyzers, flow cytometry and HCS software solutions. moreNov. 11, 2010

Frost & Sullivan: Energy-efficiency Concerns Affect the Total Pumps Market in the European ...

The European pharmaceutical industry has managed to remain insular to the economic crisis due to government-aided stimulus packages. The demand for pumps in the European pharmaceutical industry is expected to increase because of certain re-initiated projects in the recovering economies. Product types including centrifugal, peristaltic and lobe pumps will have a significant rise in their revenue shares in the total market triggered by competitive factors like total cost of ownership and energy efficiency. moreSep. 13, 2010

Mid-market Activity

While financial services (FS) deal activity has failed to live up to recovery predictions cast at the beginning of year, further industry-wide restructuring and investment for growth has resulted in a flow of mid-market deals. This is according to the latest ‘European Financial Services M&A Insight' report from PricewaterhouseCoopers LLP (PwC). moreJul. 01, 2009

Chiral Conundrums

Racemates - With the ongoing pressure within the pharmaceutical industry to develop new products and keep them protected for as long as possible from generic companies regulatory battles are brewing. Many medicines are chiral molecules; that is they exist in different forms, or enantiomers, that are mirror images of each other, and these forms are known as "S" and "R" or (+) and (-). Chiral compounds can exist as 50/50 mixtures of the single enantiomers, when they are known as racemates. more